A Phase II, Randomized, Prospective, Double blind, Parallel group, Multi-center Study to determine the Safety and Efficacy of GRANEXIN GEL in the Treatment of Diabetic Foot Ulcers

Trial Profile

A Phase II, Randomized, Prospective, Double blind, Parallel group, Multi-center Study to determine the Safety and Efficacy of GRANEXIN GEL in the Treatment of Diabetic Foot Ulcers

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs ACT 1 (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jul 2013 Positive data will be reported at the International Gap Junction Conference (IGJC), according to a FirstString media release. Top-line data were reported in the media release.
    • 15 Jul 2013 Primary endpoint 'Wound-closure' has been met, according to a FirstString media release.
    • 24 Jul 2012 Actual initiation date changed from 7 Sep 2011 to 7 Oct 2011 as reported by Clinical Trials Registry - India.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top